$139/mo
Semaglutide
Weekly GLP-1. Care, coaching and shipping included.
Get startedHome / Semaglutide dosage chart
Dosing, made clear.
Compounded semaglutide dosage chart: mg to units, checked
On a U-100 insulin syringe, units = dose in mg ÷ vial strength in mg/mL × 100. At 2.5 mg/mL, 0.25 mg is 10 units and 2.4 mg is 96 units. Your prescription sets your dose. If anything doesn’t match, call or text NexLife before you inject.
- A chart for five doses and five vial strengths
- A converter for any dose and strength
- One number to call: (949) 818-8000, 24/7
Published by NexLifeLegitScript-certifiedUpdated October 13, 2026Medically reviewed by the NexLife clinical team, led by Adam Kennah, MD (NPI 1144260043)
Semaglutide mg to units
10 units0.10 mL on a U-100 insulin syringe
For checking your math, not changing your dose. Compounded semaglutide isn’t FDA-approved; your prescription sets your dose.
Check my eligibility, $139/mo
4.8 out of 5 on Trustpilot · LegitScript certified
Compounded medicines aren’t FDA-approved. A NexLife provider prescribes one only if it offers a significant difference for you compared with an FDA-approved medicine.
The chart
Semaglutide mg to units, at the strengths you’ll see
Find your dose on the left and your vial’s strength across the top.
| Dose | 1 mg/mL | 2 mg/mL | 2.5 mg/mL | 3 mg/mL | 5 mg/mL |
|---|---|---|---|---|---|
| 0.25 mg | 25 units | 12.5 units | 10 units | 8.3 units | 5 units |
| 0.5 mg | 50 units | 25 units | 20 units | 16.7 units | 10 units |
| 1 mg | 100 units | 50 units | 40 units | 33.3 units | 20 units |
| 1.7 mg | Over 1 mL | 85 units | 68 units | 56.7 units | 34 units |
| 2.4 mg | Over 1 mL | Over 1 mL | 96 units | 80 units | 48 units |
Every cell uses one formula: units = dose in mg ÷ vial strength in mg/mL × 100.
Small doses, big differences. 10 units is 0.25 mg from a 2.5 mg/mL vial, but 0.5 mg from a 5 mg/mL vial. Recheck the strength on every new vial’s label.
The schedule
How semaglutide doses usually step up
This is the FDA-approved Wegovy injection schedule; your prescription comes first.
| Weeks | Weekly dose | What happens |
|---|---|---|
| 1 to 4 | 0.25 mg | Starting dose, to let your body adjust |
| 5 to 8 | 0.5 mg | Step two |
| 9 to 12 | 1 mg | Step three |
| 13 to 16 | 1.7 mg | Step four; some people stay here |
| 17 and on | 2.4 mg | The usual maintenance dose |
Your provider may slow the steps or keep you at a lower dose if side effects are hard. Compounded semaglutide follows your prescription.
Vial math
Why you may have medicine left on day 28
The 28-day limit
The FDA recommends using an opened multiple-dose vial within 28 days of the first needle (or by the label’s date, if sooner), even if some is left.
An example
A 2 mL vial at 2.5 mg/mL holds 5 mg. At 0.25 mg a week, four doses use 1 mg, and the rest is discarded on day 28.
Plan the next vial
Tell us when your dose changes. We line up your next vial with the pharmacy so the strength fits.
Two medications.
One flat price each.
Both are prepared by state-licensed 503A partner pharmacies and shipped free. Your provider helps you decide which one fits.
$169/mo
Tirzepatide
Weekly and dual-action. Care, coaching and shipping included.
Get startedWhat’s inside every plan
- Semaglutide: compounded, acts on the GLP-1 pathway, taken once a week
- Tirzepatide: compounded, acts on two hormone pathways (GIP and GLP-1), taken once a week
- Prepared by state-licensed 503A partner pharmacies
- A licensed provider who reviews your history and follows your dose
- A personalized nutrition plan and a 1:1 coaching call
- Free expedited shipping; orders usually ship within 1 to 2 business days
- 24/7 support from real people, plus physician access during clinical hours
- HSA and FSA cards accepted, and Klarna or Afterpay at checkout
- Prefer no injections? Ask about the sublingual tablet, at its own flat price
Prescription required. Compounded medications are not FDA-approved, and a provider prescribes one only if it offers a significant difference for you compared with an FDA-approved medicine. On 12-month plans: $139 a month for tirzepatide, $119 for semaglutide, still the same at every dose. Prices checked October 7–13, 2026.
Your dose goes up.
Your price doesn’t.
No membership, no dose surcharges, no surprises. One flat, all-inclusive monthly price at every dose.
| Month one | Month two | Month three | Every month after | |
|---|---|---|---|---|
| Semaglutide | $139 | $139 | $139 | $139 |
| Tirzepatide | $169 | $169 | $169 | $169 |
Paying less somewhere else? Send us a receipt from another licensed U.S. telehealth provider and we’ll match your regular monthly price. See the terms
Month-to-month plan, all-inclusive. Longer plans cost less and stay flat. Tirzepatide is $159, $149 and $139 a month on 3-, 6- and 12-month plans. Semaglutide is $132, $125 and $119.
What would you pay with NexLife?
Tap where you are now. We’ll show your NexLife price next to it, or tell you we’ll match it.
Pick one above to see your price.
Not today?
Prices from each provider, checked October 7–13, 2026. Brand-name and compounded medications are different products; compounded medications are not FDA-approved. †Price Match Guarantee terms apply.
The NexLife Price Match Guarantee
Keep your price.
Upgrade your care.
Already on compounded tirzepatide or semaglutide? Bring your price to NexLife. If you pay less with another licensed U.S. telehealth provider, we match your regular monthly price for as long as your plan stays active.† You keep your price, and you gain a provider who follows your dose, a personal nutrition plan, a 1:1 coaching call and real people who answer 24/7.
- 1Send a receipt from the last 60 days
- 2A NexLife provider reviews your prescription
- 3Pay your matched price, at every dose
Locked while your plan is activeSame price at every doseNo membership fee
†NexLife Price Match Guarantee: for new members switching from a licensed U.S. telehealth provider with an active prescription for compounded tirzepatide or semaglutide. Send a receipt from the last 60 days and we match your regular all-in monthly price on the month-to-month plan, for the same medication (medication plus required fees; not first-month offers, sale prices, coupons or prepaid multi-month rates), for as long as your plan stays active. A NexLife provider must determine that treatment is right for you. Not open to people with Medicare, Medicaid or TRICARE coverage. Full terms.
Avoid these
The mistakes behind most dosing errors
- Confusing mL and units. 0.1 mL is 10 units on a U-100 syringe, not 1 unit.
- Skipping the strength check. A new vial with a different strength changes your units.
- Taking a salt form. If the label says “semaglutide sodium” or “acetate,” don’t use it. Call or text us.
- Stepping up early. The FDA has reports of side effects from dose increases faster than the label schedule.
Unsure about a dose? Ask first.
Call or text NexLife at (949) 818-8000, 24/7. We check with your provider and the pharmacy, and get back to you before your next dose.
Semaglutide dosing questions
How many units is 0.25 mg of semaglutide?
At 2.5 mg/mL, 10 units. At 5 mg/mL, 5 units. At 1 mg/mL, 25 units. Units = mg ÷ mg/mL × 100.
How many units is 0.5 mg of semaglutide?
At 2.5 mg/mL, 20 units. At 5 mg/mL, 10 units. At 2 mg/mL, 25 units.
How many units is 1 mg of semaglutide?
At 2.5 mg/mL, 40 units. At 5 mg/mL, 20 units.
How many units is 2.4 mg of semaglutide?
At 2.5 mg/mL, 96 units. At 5 mg/mL, 48 units. At 3 mg/mL, 80 units.
What is the starting dose of semaglutide for weight loss?
On the Wegovy label, 0.25 mg once a week for 4 weeks, then 0.5 mg, 1 mg and 1.7 mg for 4 weeks each, then 2.4 mg. Your provider sets your schedule.
What if I miss a semaglutide dose?
On the Wegovy label: if your next dose is more than 2 days away, take the missed dose as soon as you can; if it’s less than 2 days away, skip it. Ask your provider what applies to your prescription.
Who do I call with a dosing question?
NexLife, always: call or text (949) 818-8000, 24/7. We check with your provider and the pharmacy and get back to you before your next dose.
Important safety information
Compounded tirzepatide and semaglutide are not FDA-approved, and the FDA hasn’t reviewed them for safety, effectiveness or quality. A provider prescribes them only when they offer a significant difference for you compared with an FDA-approved product. Both medicines may cause thyroid tumors, including cancer: don’t use either if you or a family member has had medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2).
Read the full safety information
In studies with rodents, both medicines caused thyroid tumors; it isn’t known whether they cause them in people. Tell your provider if you notice a lump or swelling in your neck, hoarseness, trouble swallowing or shortness of breath.
Serious side effects can include inflammation of the pancreas (pancreatitis), gallbladder problems, low blood sugar (especially with insulin or sulfonylureas), kidney problems from dehydration, severe stomach problems, serious allergic reactions, vision changes in people with type 2 diabetes, and a faster heart rate. Tell your care team before any surgery or procedure that uses anesthesia or deep sedation. Don’t combine either medicine with other GLP-1 medicines.
Tirzepatide can make birth control pills less effective: switch to a non-oral method, or add a barrier method such as condoms, for 4 weeks after you start and for 4 weeks after each dose increase. Both medicines may harm an unborn baby. Semaglutide should be stopped at least 2 months before a planned pregnancy. Tell your provider right away if you’re pregnant, planning to be, or breastfeeding.
This is a summary, not the complete safety information. Read the full Prescribing Information for FDA-approved tirzepatide (Zepbound) and semaglutide (Wegovy), and talk with your provider. You can report side effects to the FDA at 1-800-FDA-1088 or fda.gov/medwatch.
Who checked this page
Adam Kennah, MDMedical Director, NexLife · Board-certified in emergency medicine · NPI 1144260043
Leads the NexLife clinical team, which medically reviewed this page on October 12, 2026.
NexLife editorial teamResearch and pricing
the Wegovy label and the FDA’s guidance on dosing errors with compounded GLP-1s (updated October 1, 2026)
- Every fact, sourced. Each price and rule links to the page it comes from.
- How we make money. NexLife is a telehealth provider. We earn revenue when people join NexLife.
- Corrections, fast. See something wrong or out of date? Email care@nexlife.us and we’ll fix it.
One price at every dose
Dosing questions, answered by people.
Start online in about 3 minutes. A licensed provider sets your dose, and our team is there 24/7.
- 1Tell us about you
A short online health assessment, about 3 minutes.
- 2A licensed provider reviews it
You’re prescribed only if treatment is right for you.
- 3We ship it, then stay with you
Our partner pharmacy usually ships within 1 to 2 business days. Free shipping, 24/7 support.
Sources
- Novo Nordisk. Wegovy (semaglutide) prescribing information.
- U.S. Food and Drug Administration. FDA’s concerns with unapproved GLP-1 drugs used for weight loss.
- Centers for Disease Control and Prevention. Preventing unsafe injection practices (multi-dose vials).
- NexLife. Compounded semaglutide plans.
- Eli Lilly and Company. Zepbound (tirzepatide) prescribing information.
- LegitScript. Certification lookup for nexlife.us.
- NexLife. Compounded tirzepatide plans.